EU Health and Food Safety’s Post

Transcript

The Committee for Veterinary Medicinal Products is the European Medicines Agency committee responsible for veterinary medicines. It plays a key role in the authorization of veterinary medicines in the European Union by conducting the evaluation of marketing authorization applications. We determine if a veterinarian medicine meets the necessary quality, safety and efficacy requirements and whether it has a positive benefit risk balance. If so, we recommend the European Commission. To authorize the product for use in the EU. Also, continuously monitor the safety of veterinary medicines and, if needed, we recommend changes to the marketing authorization or even the withdrawal of suspension from the market. The European law requires that food such as milk, meat or eggs are free from harmful levels of veterinary drug residues. It is our job to recommend safe limits for such substances to protect consumers. For over 20 years we've been committed to the One Health approach with recognizes the connection between animal health, human health, which means the user and the consumer, and the environment. At the CVP, we work with this mindset to protect not only the animal but also public health and the environment. The committee meets once a month and is composed of scientific experts from each EU country. When the application process starts, the CMP appoints a rapporteur and a Co rapporteur. To lead the scientific evaluation, all members can comment at different stages of the procedure. These complex peer review system safeguards accuracy and validity of the opinions. The committee can also appoint members based on the specific scientific competence. They are nominated by the Member States or by the agency and recruited. For example, when expertise such as quality, antimicrobial resistance or environmental risk assessment is not available among the members and the alternates. Experts on general clinical veterinary practice can also provide valuable insights into veterinary daily practice during the meetings. Based on the Committee recommendations, the European Commission takes a legally binding decision on whether or not to authorize the veterinary medicinal product. Once granted, the centralized marketing authorization is valid in all EU Member States as well as in the European Economic Area countries.